Grace Halsey

1 week ago | patientcareonline.com | Grace Halsey

The calcitonin gene-related peptide (CGRP) inhibitor atogepant (Qulipta; AbbVie) demonstrated superior tolerability and efficacy compared to the anticonvulsant topiramate (Topamax) in the phase 3 TEMPLE head-to-head study for migraine prevention, according to an announcement from AbbVie.

1 week ago | patientcareonline.com | Grace Halsey

Huxley Medical announced1 that clinical validation results for its SANSA home sleep apnea (OSA) test have been published in the journal Frontiers in Neurology. The multicenter study of 340 participants demonstrated performance of the wireless chest-worn patch comparable to in-laboratory polysomnography (PSG).

1 week ago | patientcareonline.com | Grace Halsey

A large Taiwanese cohort study found that initiating fecal immunochemical test (FIT) screening in adults aged 40 to 49 years, rather than at the standard age of 50, significantly reduces colorectal cancer (CRC) incidence by 21% and mortality by 39% over nearly 2 decades of follow-up.

1 week ago | patientcareonline.com | Grace Halsey

Fecal microbiota transplantation (FMT) proved noninferior to vancomycin for treating primary Clostridioides difficile infection in a randomized controlled trial, with 66.7% of FMT patients achieving clinical cure without recurrence compared to 61.2% receiving standard vancomycin therapy. The findings suggest FMT could serve as first-line therapy for initial C.

1 week ago | patientcareonline.com | Grace Halsey

A randomized controlled feeding study of 102 adults with type 2 diabetes (T2D) found that a modified DASH diet with reduced sodium lowered systolic blood pressure (SBP) by 4.6 mm Hg and diastolic blood pressure (DPB) by 2.3 mmHg compared with a typical American diet with higher sodium, even among participants taking multiple antihypertensive medications.